Vmbook Online ordering

Polymedix Inc

Polymedix Inc. was a publicly traded biotechnology company based in the United States. The company was focused on the development of innovative anti-infective therapies for the treatment of serious and life-threatening infections. However, I couldn't find any recent information suggesting that the company is still publicly traded or operating.

At some point, the company was listed on the NASDAQ stock exchange under the ticker symbol PMDX. However, according to NASDAQ's website, the company's stock was delisted on November 18, 2013. The delisting might have been due to various reasons, including the company's inability to maintain the required minimum bid price for its shares, financial difficulties, or bankruptcy.

Since the delisting, I could not find any updated information about Polymedix Inc. or its operations. It is possible that the company has ceased operations or underwent significant restructuring, mergers, or acquisitions.

Please note that the information available might not be up-to-date, and it is always a good idea to conduct additional research using reputable sources for the most accurate and current information on the subject.